表紙
市場調査レポート

消化管出血:世界の治験動向

Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 229137
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
消化管出血:世界の治験動向 Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2015
出版日: 2015年04月28日 ページ情報: 英文 68 Pages
概要

当レポートでは、消化管出血に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 消化管出血
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域

G7諸国における治験件数: 消化管出血治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:消化管出血治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験 消化管出血

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 消化管出血治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • Troikaa Pharmaceuticals Ltd.
    • Johnson & Johnson
    • Galenica Ltd.
    • Covidien plc (Inactive)
    • Celgene Corporation
    • AstraZeneca PLC
    • 旭化成
  • 代表的な研究機関/病院の治験の概要
    • Shandong Provincial Hospital
    • Aarhus University
    • Centre Hospitalier Universitaire - Hopitaux de Rouen
    • Chinese PLA General Hospital
    • Chinese University of Hong Kong
    • Far Eastern Memorial Hospital
    • Hadassah Medical Organization
    • Hospital Clinic de Barcelona
    • Hospital Universitari de Bellvitge
    • 神戸大学

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2658CTIDB

GlobalData's clinical trial report, "Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2015" provides data on the Gastrointestinal Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastrointestinal Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Gastrointestinal Hemorrhage
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Gastrointestinal Hemorrhage
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Gastrointestinal Hemorrhage Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Troikaa Pharmaceuticals Ltd.
      • Clinical Trial Overview of Troikaa Pharmaceuticals Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Galenica Ltd.
      • Clinical Trial Overview of Galenica Ltd.
      • Covidien plc (Inactive)
      • Clinical Trial Overview of Covidien plc (Inactive)
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Asahi Kasei Corporation
      • Clinical Trial Overview of Asahi Kasei Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • Shandong Provincial Hospital
      • Clinical Trial Overview of Shandong Provincial Hospital
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Clinical Trial Overview of Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Chinese PLA General Hospital
      • Clinical Trial Overview of Chinese PLA General Hospital
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Far Eastern Memorial Hospital
      • Clinical Trial Overview of Far Eastern Memorial Hospital
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Hospital Clinic de Barcelona
      • Clinical Trial Overview of Hospital Clinic de Barcelona
      • Hospital Universitari de Bellvitge
      • Clinical Trial Overview of Hospital Universitari de Bellvitge
      • Kobe University
      • Clinical Trial Overview of Kobe University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Gastrointestinal Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Covidien plc (Inactive), 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahi Kasei Corporation, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong Provincial Hospital, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire - Hopitaux de Rouen, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese PLA General Hospital, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitari de Bellvitge, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2015*

List of Figures

  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Gastrointestinal Hemorrhage to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Gastrointestinal Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Gastrointestinal Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top